Frozen vs. Fresh Embryo Transfer: IVF Results

A frozen embryo transfer (FET) is the process of thawing a previously vitrified embryo and transferring it to the uterus in a subsequent menstrual cycle - separate from the ovarian stimulation and egg retrieval cycle in the IVF treatment process. This approach has several significant advantages over fresh embryo transfer, and frozen transfers now make up a large and growing share of IVF cycles internationally. Whether that shift is driven by evidence of better outcomes or by what is convenient for laboratories and scheduling is a fair question, and the regulator's rating below suggests the case is not settled (HFEA on embryo freezing).

Why Choose a Freeze-All Strategy?

The shift from fresh to frozen transfer is driven by three factors:

• Endometrial receptivity: During an IVF stimulation cycle, the high estrogen levels produced by multiple developing follicles can impair endometrial receptivity. The uterine lining may develop too quickly or too thickly, creating a timing mismatch between embryo development stage and endometrial window of implantation. By transferring in a subsequent cycle, the endometrium is prepared under controlled, physiological conditions.
• OHSS prevention: For women at risk of ovarian hyperstimulation syndrome (OHSS), pregnancy in the same cycle as stimulation significantly worsens the condition. A freeze-all strategy eliminates this risk.
• PGT testing: Genetic analysis requires 1-2 weeks for results. By vitrifying all embryos and waiting for PGT results, only confirmed euploid embryos are selected for transfer.

How Does Vitrification Actually Work?

The reason a freeze-all strategy is possible at all is a change in freezing technique. Older methods lowered the temperature slowly, and slow cooling gives the water inside a cell time to organize itself into ice crystals. Ice is not gentle: crystals tear membranes and disrupt the internal architecture of an embryo. Survival was unreliable, which is why freezing an embryo was once a gamble taken only when there was no alternative.

Vitrification takes the opposite approach. The embryo is first bathed in cryoprotectant solutions that draw water out and replace it, then cooled so abruptly that the remaining liquid has no opportunity to crystallise. Instead it sets into a glass-like solid — vitrification means "to turn into glass" — with the embryo's structures held exactly as they were. It is then stored in liquid nitrogen, where biological time effectively stops. Nothing ages and nothing degrades, so an embryo stored for years is, on warming, the same embryo it was on the day it was frozen.

Warming reverses the process: the sample is brought back to temperature quickly and the cryoprotectants are washed out in stages so the embryo can rehydrate without shock. An embryologist then examines it and reports whether it has survived intact. This is the moment patients dread, and it is worth saying plainly that with modern technique the great majority of embryos come through it.

Because so much rests on the laboratory, it is fair to ask about it. Storage tanks should be alarmed and monitored continuously, samples should be labeled and witnessed at every step, and the unit should be able to quote its own survival figures rather than the published literature. A clinic that cannot answer those questions comfortably is telling you something.

What the UK Regulator Says About Freeze-All

The HFEA rates elective freeze-all as a treatment add-on, and its ratings are more interesting here than for most, because they split by what you are trying to achieve.

• Green for reducing the risk of OHSS. Freeze-all is proven effective at reducing ovarian hyperstimulation syndrome, both for patients generally and for those at increased risk of it. Green is the top of the HFEA's scale and this is the only one we have found in the fertility add-ons relevant to this site.
• Amber for improving the chance of a baby for most patients. Amber means it is not clear: there is conflicting moderate-to-high quality evidence, effective in some studies and not in others.
• Grey for reducing adverse obstetric or neonatal outcomes. The HFEA cannot rate it, because there is not enough good-quality evidence.

Read together, that says something useful: freeze-all is a safety tool with good evidence behind it, and a success tool with unclear evidence behind it. If it is being recommended to you to avoid OHSS, that recommendation is well supported. If it is being recommended as the thing that will improve your odds, ask what evidence the clinic is relying on. You can read the ratings and the reasoning on the HFEA's elective freeze-all page.

A clinic in Turkey is not HFEA-licensed, so these ratings are guidance to you rather than a rule binding on the clinic, and there is no HFEA inspection or complaints route behind the treatment.

The Part Usually Left Out: Fresh and Frozen Carry Different Pregnancy Risks

Most comparisons of fresh and frozen stop at whether you get pregnant. The choice also shapes the pregnancy that follows, and the differences run in opposite directions - which is why neither option is simply safer.

• After a frozen transfer, rates of high blood pressure in pregnancy, including pre-eclampsia, are reported higher, and babies are more likely to be large for gestational age.
• After a fresh transfer, babies are more likely to be born preterm, or small for gestational age and low birth weight.

The explanation most often offered for the frozen side is the corpus luteum - the structure left behind after ovulation, which produces hormones involved in how the placenta establishes itself. In a programmed frozen cycle, where the lining is prepared with oestrogen and progesterone and ovulation is suppressed, there is no corpus luteum at all. In a natural or modified natural frozen cycle, where the transfer is timed to your own ovulation, there is one.

That gives you a specific question worth asking: will my frozen transfer be a programmed cycle or a natural one, and why that choice for me? Programmed cycles are easier to schedule, which matters when you are flying in for the transfer - so if the answer is about the calendar rather than about your body, it is worth saying that you would rather know.

None of this is a reason to refuse a frozen transfer. These are differences in risk across large populations, not predictions about you, and the absolute numbers remain small. It is a reason to have the conversation with an obstetric team as well as a fertility one, and to mention how you conceived at your first antenatal appointment, because it changes what your midwife watches for.

When Is a Fresh Transfer Still the Better Choice?

Freeze-all has become the default at many centers, and defaults deserve scrutiny. A frozen transfer is not automatically better for everyone, and a clinic that never performs a fresh transfer is applying a policy rather than making a decision. Fresh transfer remains reasonable, and sometimes preferable, in several situations.

• A straightforward response to stimulation: Where estrogen stays within a physiological range, the lining develops normally, and there is no OHSS concern, the argument for freezing weakens considerably. In normal responders the evidence has not shown a clear advantage either way.
• Very few embryos: If a single embryo reaches transfer stage, freezing and warming introduce a step — however reliable — that a fresh transfer avoids entirely.
• No genetic testing planned: Much of the case for freeze-all rests on waiting for PGT results. Without PGT, that particular reason disappears.
• Cost and time constraints: A frozen cycle adds freezing fees, storage charges, another round of monitoring, and weeks of delay. For patients funding treatment themselves or traveling from abroad, that is a real consideration rather than a footnote.
• Cycles where delay carries its own cost: Time is not a neutral commodity for every patient.

Conversely, freezing is clearly the safer course where OHSS is a genuine risk, where PGT is planned, where progesterone has risen prematurely during stimulation, or where the lining has not developed as it should. Ask your specialist which of these applies to you, and ask them to explain why — "it is our protocol" is not a reason.

What Happens During a Frozen Embryo Transfer?

Option 1: Medicated (Hormone Replacement) FET

The most commonly used protocol:

1. Day 1-2 of period: Baseline ultrasound and blood work to confirm no residual cysts or issues.
2. Days 1-14: Oral or transdermal estrogen (estradiol) to build the endometrial lining. Target: ≥7 mm thickness with trilaminar (triple-line) pattern on ultrasound.
3. Day ~14: Lining check ultrasound. If adequate, progesterone is initiated.
4. Progesterone days 1-5: Intramuscular or vaginal progesterone transforms the endometrium from proliferative to secretory phase - creating the implantation window.
5. Day 5 of progesterone: Embryo thaw and transfer. A vitrified blastocyst is warmed (2-3 minutes), assessed for survival (published studies report survival of around 95-99%), and transferred to the uterus via a thin catheter under ultrasound guidance. The procedure takes 5-10 minutes, needs no anesthesia, and is usually painless.
6. Post-transfer: Continue estrogen and progesterone. Pregnancy test (beta-hCG blood test) at 10-12 days post-transfer.

Option 2: Natural Cycle FET

For women with regular ovulatory cycles:

1. Monitor natural follicle development and ovulation via ultrasound and blood tests (LH surge)
2. Transfer timed to 5 days after ovulation (for blastocysts) or 3 days after ovulation (for Day 3 embryos)
3. No or minimal exogenous hormones - progesterone supplementation may or may not be added

Natural cycle FET produces equivalent success rates to medicated cycles in women with reliable ovulation (ESHRE) but requires more monitoring visits to capture the ovulation window precisely.

Medicated or Natural Cycle: Which Protocol Suits You?

Both protocols aim at the same thing — a lining that is ready at the moment the embryo is ready — and both achieve it. The difference lies in how that timing is produced, and in what each asks of you.

For patients traveling internationally, the practical argument usually settles it: a medicated cycle can be booked around flights and leave, while a natural cycle asks you to be available when your body decides. That is a scheduling judgment rather than a clinical one, but it is a legitimate thing to weigh, and a good clinic will weigh it with you rather than for you.

What Is ERA Testing and Who Needs It?

ERA (Endometrial Receptivity Analysis) is a molecular test that determines each woman's personal "window of implantation" - the specific hours during which the endometrium is most receptive to embryo attachment. Approximately 25% of women with recurrent implantation failure have a displaced window - meaning the standard Day 5 progesterone timing doesn't match their individual biology.

ERA involves a mock transfer cycle with a small endometrial biopsy analyzed for gene expression patterns, and the results shift transfer timing by 12-24 hours in either direction.

The HFEA rates endometrial receptivity testing red, meaning moderate-to-high quality evidence suggests it may reduce treatment effectiveness. Its reasoning is worth understanding, because it is not simply "unproven": if the test is inaccurate, or if the window of implantation shifts from cycle to cycle, then acting on the result moves your transfer away from the right day rather than towards it. A mock cycle also costs a month and a biopsy.

That does not mean no clinic should ever offer it. It means that if it is proposed to you, ask what evidence they are relying on given the rating, what it costs, and what they would do differently with the result. It is one of the add-ons most often sold to people who have already had transfers fail, which is exactly when it is hardest to say no to something.

What Are Frozen Embryo Transfer Success Rates?

• PGT-A euploid blastocyst FET: 50-65% clinical pregnancy rate per transfer (ASRM)
• Untested blastocyst FET (age <35 at retrieval): 40-50%
• Untested blastocyst FET (age 35-40): 30-40%
• Cumulative success (2-3 euploid FET cycles): 80-90%

At partner IVF centres, FET is performed using the same vitrification technology used for egg freezing, the approach published studies associate with high embryo survival after thawing. Both medicated and natural cycle protocols are offered, with ERA testing available for patients with previous implantation failure. Transparent pricing for FET cycles includes monitoring, embryo thaw, transfer, and progesterone support.

Questions to Ask Your Fertility Specialist

Protocol choices in frozen transfer are finely balanced, and what suits one patient will not suit another. Published rates describe groups of people, not you — so the useful conversation is about your own embryos, your own cycle, and the laboratory that will actually be handling them. These questions are a starting point.

• Are you recommending a frozen transfer for a specific reason in my case, or is it standard practice here?
• What survival rate does your own laboratory achieve after warming, and how is that recorded?
• Which protocol are you proposing for me, and what makes it the better fit?
• How will you confirm my lining is ready, and what would make you postpone the transfer?
• How long will I need to be in the country, and at what point can the date be confirmed?
• How long would I continue progesterone if the test is positive?
• Is ERA testing appropriate for me now, or would you reserve it for later?
• What happens to any remaining embryos, and what does storage cost each year?
• Given my history, what would you expect from this transfer — and what would you do differently next time if it does not work?

That last question matters more than it looks. A specialist who has already thought about the next step is a specialist who is planning your care rather than your cycle.